Axonics® reports first quarter 2022 financial results

Irvine, calif.--(business wire)--axonics, inc. (nasdaq: axnx), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the three months ended march 31, 2022. “we are pleased with this quarter's revenue result considering the significant impact the omicron surge had on elective procedures in january and february,” said raymond w. cohen, chief executive officer of axonics. “s
AXNX Ratings Summary
AXNX Quant Ranking